CPRX - Catalyst Pharmaceuticals Inc. (CPRX) CEO Patrick McEnany on Q3 2021 Results - Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (CPRX) Q3 Earnings Conference Call November 10, 2021, 8:30 AM ET Company Participants Patrick McEnany – Chairman and Chief Executive Officer Ali Grande – CFO Steven Miller – Chief Operating Officer and Chief Scientific Officer Jeffrey Del Carmen – Chief Commercial Officer Gary Ingenito – Chief Medical and Regulatory Officer Conference Call Participants Charles Duncan – Cantor Fitzgerald Scott Henry – ROTCE Capital Joseph – from Piper Sandler Joon Lee – Truist Presentation Operator Hello, and welcome to the Catalyst Pharmaceuticals Third Quarter 2021 earnings call and webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Ali Grande, CFO. Please go ahead. Ali Grande Good morning everyone, and thank you for joining our conference call to discuss
For further details see:
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q3 2021 Results - Earnings Call Transcript